Summary & Overview

Cervical Spinal Fusion with CC: Inpatient Reimbursement Overview

DRG 472 covers cervical spinal fusion cases with a Complication or Comorbidity, encompassing higher-complexity cervical fusion procedures and related perioperative conditions. Correct assignment affects inpatient reimbursement because the Diagnosis-Related Group reflects greater expected resource use when a Complication or Comorbidity is present.

Cervical Spinal Fusion with CCDRG Cervical Spinal Fusion with CCDRG 472Diagnosis-Related GroupInpatient ReimbursementMedicareSpine SurgeryOrthopedic SurgeryNeurosurgeryHospital Coding

DRG 472 Overview

DRG 472 covers inpatient admissions for cervical spinal fusion procedures when a Complication or Comorbidity is present; cases typically involve multilevel fusion, instrumentation, or significant perioperative issues that increase resource use. This Diagnosis-Related Group groups patients by clinical similarity and expected hospital resource consumption to determine Medicare payment for the stay. It matters for Medicare payments because the presence of a Complication or Comorbidity increases the relative weight and thus the prospective reimbursement compared with non-CC cases. Clinicians, coders, and billing staff must accurately document and code diagnoses and procedures to align the clinical record with the assigned Diagnosis-Related Group.

Clinical Trials

Acute perioperative intervention trials: Studies testing intraoperative or immediate postoperative strategies to reduce complications and improve fusion rates, such as comparing surgical techniques, bone graft materials, or blood management protocols. These trials typically enroll adult patients undergoing cervical spinal fusion who have complicating comorbidities (the “CC” population), and measure outcomes like intraoperative blood loss, neurologic events, infection, and early reoperation. Results inform surgeons and hospital administrators about which perioperative practices lower short-term morbidity and resource use for high-risk patients in this DRG.
Comparative effectiveness studies of fusion approaches and instrumentation: Head-to-head controlled studies comparing anterior, posterior, or combined cervical fusion approaches, or different fixation systems and biologic adjuncts, focusing on real-world patients with comorbid conditions and multilevel disease. These studies evaluate outcomes such as length of stay, complication profiles, fusion success, readmission, and functional recovery over months to a year, helping providers choose approaches that balance clinical benefit and cost. Payers and health systems use this evidence to shape coverage policies, preferred implants, and value-based care pathways for patients grouped under this DRG.
Post-discharge and long-term outcomes and utilization research: Observational cohort studies and registries tracking recovery trajectories, pain and functional outcomes, rehospitalization, long-term opioid use, and downstream healthcare utilization among CC patients after cervical fusion. These studies often focus on predictors of prolonged recovery or readmission in patients with medical comorbidities, and on the effectiveness of rehabilitation, care coordination, or transitional care models. Findings are relevant to discharge planning, post-acute care placement decisions, and payer efforts to reduce avoidable readmissions and total episode costs for this DRG.

Biopsies of Musculoskeletal System and Connective Tissue with MCC: Inpatient Reimbursement Overview

466-REVISION-OF-HIP-OR-KNEE-REPLACEMENT-WITH-MCC

Revision of Hip or Knee Replacement with MCC: Inpatient Reimbursement Overview

489-KNEE-PROCEDURES-WITHOUT-PRINCIPAL-DIAGNOSIS-OF-INFECTION-WITHOUT-CC-MCC

Knee Procedures without Principal Diagnosis of Infection without CC/MCC: Inpatient Reimbursement Overview

536-FRACTURES-OF-HIP-AND-PELVIS-WITHOUT-MCC

Fractures of Hip and Pelvis without MCC: Inpatient Reimbursement Overview

496-LOCAL-EXCISION-AND-REMOVAL-OF-INTERNAL-FIXATION-DEVICES-EXCEPT-HIP-AND-FEMUR-WITH-CC

Local Excision and Removal of Internal Fixation Devices Except Hip and Femur with CC: Inpatient Reimbursement Overview

493-LOWER-EXTREMITY-AND-HUMERUS-PROCEDURES-EXCEPT-HIP-FOOT-AND-FEMUR-WITH-CC

Lower Extremity and Humerus Procedures Except Hip, Foot and Femur with CC: Inpatient Reimbursement Overview

542-PATHOLOGICAL-FRACTURES-AND-MUSCULOSKELETAL-AND-CONNECTIVE-TISSUE-MALIGNANCY-WITH-MCC

Pathological Fractures and Musculoskeletal and Connective Tissue Malignancy with MCC: Inpatient Reimbursement Overview

558-TENDONITIS-MYOSITIS-AND-BURSITIS-WITHOUT-MCC

Tendonitis, Myositis and Bursitis without MCC: Inpatient Reimbursement Overview

474-AMPUTATION-FOR-MUSCULOSKELETAL-SYSTEM-AND-CONNECTIVE-TISSUE-DISORDERS-WITH-MCC

Amputation for Musculoskeletal System and Connective Tissue Disorders with MCC: Inpatient Reimbursement Overview

521-HIP-REPLACEMENT-WITH-PRINCIPAL-DIAGNOSIS-OF-HIP-FRACTURE-WITH-MCC

Hip Replacement with Principal Diagnosis of Hip Fracture with MCC: Inpatient Reimbursement Overview

Showing 1–10 of 104

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

OpenPayer

Summary & Overview

Cervical Spinal Fusion with CC: Inpatient Reimbursement Overview

DRG 472 Overview

Clinical Trials

Related Codes